Lixin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lixin

Property Description
Active ingredient Flucloxacillin (Sodium Salt)
Pharmaceutical Forms Capsules, Oral Solution/Suspension, Injection
Pharmacological Class Beta-lactam Antibacterial, Penicillin
Common Use Treating Bacterial Infections
Origin Semisynthetic

Defining the Antibiotic's Identity and Class

Lixin is a medication used to treat bacterial infections, and its active substance, Flucloxacillin, places it within the penicillin family of antibiotics. Pharmacological studies have clinically recognized Flucloxacillin as a semisynthetic isoxazolyl penicillin. The drug belongs to the broader beta-lactam antibacterial pharmacological class. A vital feature is its engineered beta-lactamase resistance, meaning it overcomes the neutralizing enzymes produced by specific bacteria, which is particularly relevant when treating common infections caused by Staphylococcus species.


Composition, Origin, and Available Forms

The therapeutic efficacy of Lixin stems from its sole active ingredient, Flucloxacillin, which is manufactured through a semisynthetic process. As a single-ingredient product, its chemical structure is derived from the natural penicillin nucleus but chemically altered to enhance its stability against stomach acid, making it suitable for the oral route of administration. Lixin is available in multiple pharmaceutical preparations to suit patient requirements, including oral capsules or a liquid solution/suspension, and as a sterile powder for injection when rapid parenteral delivery is required.


General Purpose and High-Level Action

The general purpose of Lixin is to halt the spread of bacterial growth and eliminate the underlying cause of infection. Supported by extensive clinical practice, the drug achieves this through a powerful bactericidal action, actively killing bacteria rather than just inhibiting their growth. Flucloxacillin works by interfering with the vital process of bacterial cell wall synthesis, which is essential for the pathogenic cells' structural integrity. This targeted function ensures the medicine contributes to clearing the infection and allows the patient's body to commence recovery effectively.

What side effects are possible with Lixin?

Possible Side Effects and Safety Information

The official safety profile of Lixin (Flucloxacillin) is structured by government regulatory agencies into established frequency classifications and System-Organ-Classes (SOC).

Common Adverse Reactions (affecting up to 1 in 10 individuals) primarily involve Gastrointestinal disorders, such as minor stomach upset, nausea, and diarrhoea. The overgrowth of non-susceptible organisms, which may present as oral or vaginal thrush, is also commonly documented.

Uncommon Reactions include effects on the Skin and subcutaneous tissue, such as general skin rash (exanthema) and raised, itchy patches (urticaria).

Rare and Serious Adverse Reactions

The profile addresses several rare but clinically significant safety concerns:

  • Hepatobiliary Disorders (Liver): Hepatitis and cholestatic jaundice are rare reactions that may be severe. Crucially, the onset of these liver effects can be delayed for up to two months after treatment has ended, and fatal outcomes have been reported in very rare cases.
  • Immune System: Severe hypersensitivity reactions, including anaphylactic shock, are classified as very rare and can be fatal. Other serious skin reactions, such as Acute Generalised Exanthematous Pustulosis (AGEP), are documented, sometimes occurring at the initiation of treatment.

Population-Specific Safety Considerations

The official regulatory documentation highlights an increased risk of hepatic reactions in older patients (e.g., over 50 years of age) and those receiving prolonged therapy. Lixin is formally contraindicated in individuals with a past history of flucloxacillin-associated jaundice or liver dysfunction. Caution is also advised in patients with renal impairment, as high doses may carry a risk of neurological effects.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the overdose profile of Lixin (Flucloxacillin) by documenting specific clinical manifestations and mandated emergency actions. Overdose exposure may result in acute gastrointestinal symptoms, including nausea, vomiting, and diarrhoea. At high doses, particularly in individuals with impaired kidney function, more severe effects such as neurological disorders and convulsions have been reported.

Serious Outcomes and Emergency Action

Severe systemic outcomes documented in regulatory warnings include High Anion Gap Metabolic Acidosis (HAGMA) and potentially life-threatening Hypokalaemia (low potassium levels). The official guidance mandates that users seek immediate medical attention for suspected overdose or if signs of a serious allergic reaction (Anaphylaxis) occur. Treatment is officially defined as symptomatic and supportive, and the medication is not significantly removed by haemodialysis.

Population-specific warnings highlight that newborns require special caution due to the risk of kernicterus following high-dose parenteral administration, and patients with severe renal impairment face an increased risk of neurotoxicity with high doses.

Therapeutic Uses of Lixin

What Lixin Treats: Main Uses and Benefits

Lixin (Flucloxacillin) is applied across domains where additional symptomatic support is needed to address bacterial infections and manage the resulting discomfort. Its use is centered on supporting the management of the infection and easing the resulting symptom load.

This medication is used to treat a variety of infections, primarily those caused by susceptible Gram-positive organisms.

It is commonly used across conditions presenting with acute episodes, such as cellulitis, boils, infected wounds, and sometimes more serious deep-tissue or systemic conditions like osteomyelitis or septicaemia. The medication is considered relevant when supportive symptom management may be appropriate for localized symptoms, such as redness, swelling, and pus, or systemic signs like fever.

“Lixin is commonly used to help support infection management, which may assist with easing physical discomfort and contributes to managing the infection's local effects.”

In specific scenarios, such as managing mastitis or post-injury infections, Lixin supports the patient during difficult episodes by helping to ease discomfort, and may assist with managing symptoms that interfere with daily functioning during periods of infection-related strain.


Quick Fact: Focus on Symptoms Related to Inflammatory States Lixin is used for managing symptoms related to inflammatory or irritative states, and is applied in addressing symptoms that create noticeable physiological strain, such as swelling and warmth.


Eligibility and Restrictions for Use

Who Can and Cannot Use Lixin?

Eligibility to use Lixin (Flucloxacillin) is strictly determined by official regulatory criteria, primarily based on patient history, age, and organ function. Most adults and older children are approved to use the medicine under standard conditions.

Contraindications (Must Not Use)

Use is contraindicated (absolutely prohibited) for individuals with a known history of hypersensitivity to penicillin or other beta-lactam antibiotics (such as cephalosporins). It is also strictly forbidden for patients who have previously experienced flucloxacillin-associated jaundice or hepatic dysfunction, or a diagnosis of Acute Generalized Exanthematous Pustulosis (AGEP).

Restrictions and Conditional Use

Certain populations require caution or conditional use:

  • Organ Function: Patients with severe renal impairment require dose adjustment. Individuals with evidence of active hepatic dysfunction or Porphyria must use the medicine with caution.
  • Age: Caution is advised for patients over 50 years of age. Use is not recommended in babies less than four weeks old, and extreme caution is required for jaundiced or premature infants due to specific physiological risks.
  • Pregnancy/Lactation: Use is acceptable during breastfeeding. However, safety for use has not been established during the first trimester of pregnancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Lixin (Flucloxacillin) is defined by its effects on metabolism and excretion pathways, as documented in official regulatory sources. These interactions establish necessary constraints for co-administration with other substances.

Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance/Class Official Interaction Pattern
Probenecid and Sulfinpyrazone Delays the renal tubular secretion of Flucloxacillin, leading to increased and prolonged plasma concentrations.
Voriconazole Flucloxacillin is classified as a CYP450 inducer, resulting in a significant decrease in the plasma concentration of Voriconazole.
Methotrexate Reduces the excretion of Methotrexate, leading to an increased risk of toxicity.
Bacteriostatic Agents May interfere with the bactericidal action of Flucloxacillin.

Timing and Population-Specific Constraints

Oral administration of Lixin is subject to an officially documented timing constraint with food. Food interferes with the drug's absorption, mandating that Lixin be taken on an empty stomach, at least 60 minutes before or 2 hours after a meal.

Population-specific interaction cautions are noted, particularly with Paracetamol (Acetaminophen). Co-administration has been associated with High Anion Gap Metabolic Acidosis in patients with established risk factors, such as severe renal impairment or malnutrition. Additionally, high doses in jaundiced newborns may displace bilirubin from plasma proteins.

Mechanism of Action

Irreversible Inhibition of Bacterial Cell Wall Construction

The action of Flucloxacillin involves the irreversible covalent inhibition of Penicillin-Binding Proteins (PBPs), which are bacterial transpeptidase enzymes. By forming a permanent bond with these targets, the drug immediately halts the crucial final step of peptidoglycan cross-linking, which is essential for building a strong, rigid bacterial cell wall. This molecular interference compromises the structural integrity of the cell wall.

Mechanistic Cascade to Bactericidal Lysis

The structural failure caused by PBP inhibition triggers a rapid mechanistic cascade leading to the bactericidal effect—the killing of the bacteria. The weakened cell wall cannot withstand the high internal osmotic pressure of the cell, causing the bacterial cell envelope to destabilize and rupture (lysis). The mechanism acts selectively by focusing its action exclusively on the peptidoglycan structures and PBP enzymes, which are absent in human cells.

Overcoming Bacterial Enzyme Defenses

Flucloxacillin is engineered with a structural resistance that allows its mechanism to function even in the presence of bacterial beta-lactamase enzymes. This bulky molecular side chain prevents the bacteria's defense mechanism from breaking down the beta-lactam ring, thereby preserving the drug's ability to bind to and inhibit the PBPs. The mechanism is constrained against bacteria possessing altered PBP targets.

Dosage and Administration Information

Lixin (Flucloxacillin) is administered through multiple official routes, reflecting its range of pharmaceutical forms. Approved routes include Oral administration for routine outpatient use, and parenteral routes such as Intravenous (IV) and Intramuscular (IM) injection, typically reserved for severe infections or hospital settings. Specialized routes like Intrapleural and Intra-articular administration are also utilized.

For oral use, the standard adult regimen is typically 250 mg four times a day (QID). The oral dosage must be administered on an empty stomach to ensure adequate absorption. This requires the medicine to be taken strictly one hour before or two hours after any food or meal. To maintain consistent drug levels, doses are to be spaced evenly throughout the day, generally at least four hours apart.

In cases requiring high-dose or parenteral administration, the powder for injection must be reconstituted before use. IV bolus administration must proceed slowly over a period of three to four minutes, with a maximum single adult dose of 2 g.

Dosing schedules are modified for certain patient groups. For adults with severe renal impairment (creatinine clearance <10 ml/min), the dose is reduced, commonly not exceeding 1 g every 8 to 12 hours. Pediatric dosing is determined by body weight, typically 25 to 50 mg/kg per 24 hours, administered in divided doses. The overall duration of use is determined by the specific type and severity of the infection.

Recent Clinical Evidence

Lixin: Recent Clinical Evidence

Clinical evidence for Lixin (Levofloxacin Infusion), a quinolone antibiotic, focuses primarily on its effectiveness and safety in treating various bacterial infections.


Efficacy in Common Infections

Lixin, which works by inhibiting the bacterial DNA gyrase enzyme essential for bacterial growth, has been studied in the treatment of a broad spectrum of infections. Clinical data supports its use for infections in several areas:

  • Respiratory Tract: Effective against bacterial pneumonia and bronchitis.
  • Urinary Tract: Utilized for infections affecting the bladder and kidneys.
  • Skin and Soft Tissues: Demonstrated efficacy in managing bacterial infections of the skin and underlying tissues.
  • Prostate: Prescribed for bacterial prostatitis.

Trials consistently show Lixin's ability to eliminate the harmful bacteria responsible for these illnesses, often leading to a relatively quick alleviation of symptoms. Patients are advised to complete the full prescribed course to ensure complete eradication of the bacteria and to mitigate the risk of developing antibiotic resistance.


Safety Profile and Adverse Reactions

In clinical settings, Lixin Infusion is generally well-tolerated, though some patients may experience side effects. The most commonly reported adverse events are often gastrointestinal, which is typical of many antibiotic classes. These can include:

System Affected Common Adverse Reactions
Gastrointestinal Nausea, Diarrhea, Constipation
Central Nervous System Headache, Dizziness
Injection Site Pain, Redness, Swelling

Serious adverse events are rare. Due to the nature of quinolone antibiotics, prescribers and patients are closely monitored for potential tendon issues. Lixin is typically administered intravenously by a healthcare professional, especially in hospitalized patients or those unable to take oral medication, ensuring proper dosage and monitoring of potential infusion-related reactions. Longer-term, larger trials continue to confirm the established safety and efficacy profile of Levofloxacin-containing products for their approved indications.

Frequently Asked Questions (FAQ)

Common questions about Lixin (FAQ)

Q: Is Lixin the same kind of medicine as [similar common drug name]?

A: Lixin is officially categorized as a penicillin class antibiotic. Prescribing information describes it as a beta-lactamase-resistant penicillin, which means its structure allows it to work against certain bacteria that have developed resistance to some older types of penicillin.

Q: Does Lixin make you tired or drowsy?

A: Official documents do not list tiredness or drowsiness as common side effects of Lixin. However, regulatory caution is noted regarding the potential for neurological effects when the drug is given in high doses to patients who have severe kidney impairment.

Q: Can Lixin affect my mood or mental focus?

A: Changes to mood or mental focus are not described as typical side effects in official product information. Nevertheless, the prescribing information notes a risk of neurological effects when high doses are used in patients with severe kidney impairment.

Q: What kind of side effects are considered serious for Lixin?

A: Serious adverse reactions described in official documents include anaphylactic shock (a severe allergic reaction) and severe liver problems, such as hepatitis and cholestatic jaundice. Very rare instances of fatal outcomes have been reported, primarily associated with severe liver dysfunction in certain patient populations, such as older adults.

Q: Does Lixin have any known risks for the liver?

A: Yes, official safety information documents hepatitis and cholestatic jaundice as rare reactions. The onset of these liver effects can be delayed for up to two months after treatment is completed, and the risk is considered higher in adults over the age of 50.

Q: What if Lixin makes my stomach upset? Is that normal?

A: Yes, gastrointestinal disorders such as stomach upset, nausea, and diarrhea are listed in official documents as common adverse reactions. This means they are experienced by up to 1 in 10 individuals using the medication.

Q: How long does Lixin typically stay in my system?

A: Lixin is primarily eliminated by the kidneys. While the excretion rate is generally rapid, the drug's full pharmacokinetic description defines the specific timeline for complete elimination from the body. Understanding the specific timeline for complete elimination is complex and depends on a review of individual patient factors by a healthcare professional.

Q: What happens if I miss taking Lixin one day?

A: Patient information advises that if a dose is missed, it should be taken as soon as it's remembered, then continue with the usual dosing schedule. However, it's advised to wait about four hours before taking the next dose. The guidance specifies that a double dose should not be taken to compensate for a missed dose.

Q: Do I need to stop taking Lixin suddenly?

A: Lixin must be discontinued immediately if a severe allergic reaction (like anaphylaxis) or a serious skin reaction occurs. The expected general course of therapy involves completing the full prescribed duration, unless a healthcare professional determines a need for premature discontinuation.

Q: What kind of research has been done on Lixin?

A: Research includes clinical trials focusing on the drug's effectiveness against various bacterial infections and studies on its safety profile. Official research also examines how it interacts with other medications through enzyme induction in the body.

Q: Is Lixin something I have to take every day?

A: Lixin is prescribed for a specific course of treatment determined by the type and severity of the infection. The course is not indefinite, but rather defined for a set number of days or weeks, and the full course must be completed as prescribed.

Q: Is it true that Lixin is only for adults?

A: No. Official dosage guidelines are provided for adults and older children based on body weight. However, Lixin is not recommended for use in premature babies or infants less than four weeks old.

Q: Do I need any special monitoring or blood tests while on Lixin?

A: For prolonged treatments (such as for certain bone or heart infections), official prescribing information recommends regular monitoring of hepatic (liver) and renal (kidney) functions through routine clinical methods.

Q: Why is Lixin considered a prescription drug?

A: Lixin is classified as a prescription medicine due to its powerful use as an antibacterial agent, which requires careful diagnosis. Its status also reflects the need for dose adjustment in certain patient populations and the potential for rare but serious side effects like severe allergic reactions.

Q: Are there different versions or strengths of Lixin available?

A: Yes. Lixin is available in different pharmaceutical forms, including capsules or a liquid solution for oral use, and a sterile powder for injection. Common oral strengths include 250 mg and 500 mg.

Q: Does Lixin work by changing hormone levels?

A: Lixin's primary mechanism is bactericidal; it kills bacteria by irreversibly inhibiting the construction of their cell walls. Official prescribing information does not describe its primary action as changing hormone levels.

Q: Why do some people say Lixin did not work for them?

A: Lixin works only against susceptible bacteria. Official documents note that the drug is constrained against bacteria that have developed resistance. Additionally, prolonged use may lead to the overgrowth of non-susceptible organisms, which can affect outcomes.

Q: Can I take Lixin if I have a history of kidney problems?

A: For patients with severe renal impairment (severe kidney problems), a dose reduction or extension of the dose interval is generally required. This adjustment helps prevent high drug levels in the body and reduces the potential risk of neurological effects.

Q: Is Lixin safe for older adults (seniors)?

A: Caution is advised for patients over 50 years of age because official safety documents show an increased risk of hepatic (liver) reactions in this group. Dosing modifications based on kidney function status are noted as a consideration in prescribing information for this population.

Q: Are there any long-term effects of using Lixin that studies have found?

A: For prolonged treatments, official documents recommend regular monitoring of liver and kidney function. A notable finding is that severe liver disorders can have a delayed onset of up to two months after treatment is finished.

Q: Does Lixin affect birth control pills?

A: Official guidance indicates that Lixin does not stop common types of hormonal contraception from working. However, if the medicine causes severe vomiting or diarrhea, this may reduce the contraceptive effectiveness.

Q: What are the rules about using Lixin for children or teenagers?

A: Specific dosing guidelines are provided for the pediatric population based on age and weight, with children over 10 years typically receiving the adult dose. Use is not recommended in infants less than four weeks old.

Q: How does the effectiveness of Lixin look in clinical trials?

A: Clinical data has demonstrated Lixin's efficacy in the treatment of a broad spectrum of bacterial infections, including those in the respiratory tract, urinary tract, and skin and soft tissues. Trials consistently show its ability to eliminate harmful bacteria.

Q: Can Lixin be taken with milk or other dairy products?

A: Oral administration of Lixin is subject to a strict timing constraint with food due to absorption interference. It must be taken on an empty stomach, at least one hour before or two hours after a meal.

Q: Why do some patient groups have special instructions for Lixin?

A: Special instructions, such as dose reduction, exist primarily because the drug is eliminated by the kidneys. Patients with severe renal impairment require adjustment to prevent the drug from building up to high levels, which could cause neurotoxicity.

Q: Is there any research on Lixin for treating chronic symptoms?

A: Official prescribing information lists conditions that require prolonged treatment, such as certain bone infections (osteomyelitis) and heart infections (endocarditis). These longer courses of treatment require regular monitoring of organ function.

Q: How does Lixin compare to older treatments for the same condition?

A: Lixin is categorized as a beta-lactamase-resistant penicillin. This means its molecular structure allows it to overcome neutralizing bacterial enzymes, which is a structural difference from older, non-resistant penicillins.

Q: Does taking Lixin mean I have to limit my sun exposure?

A: Official guidance indicates that Lixin is not typically associated with causing photosensitivity. Patients are generally not required to limit sun exposure while using this medication.

Q: Can I use Lixin if I have epilepsy or a history of seizures?

A: The official documents do not list epilepsy or a history of seizures as a formal contraindication for general use. However, caution is advised in patients with severe kidney problems receiving high doses due to the risk of neurological effects.

Q: Can I drink alcohol while using Lixin?

A: Official prescribing information does not list a specific interaction between Lixin and alcohol. However, patient guidance suggests that consuming alcohol may worsen common side effects such as stomach upset.

Q: Is Lixin ever given as an injection instead of a pill?

A: Yes. Lixin is available as a sterile powder for injection for parenteral use (IV or IM). These routes are typically reserved for patients with severe infections or those who are unable to take the oral form.

How should Lixin be stored and disposed of?

How to Store and Dispose of Lixin (Flucloxacillin)

Storage and disposal must strictly adhere to regulatory labeling to maintain product stability and safety.

Formulation Required Storage Condition
Capsules/Powder Store below 25 C and protect from moisture.
Prepared Oral Solution Store in a refrigerator (2 C to 8 C). Do not freeze.

All forms must be kept in their tightly closed original container and out of the sight and reach of children.

Stability and Handling: The prepared oral solution has a limited shelf-life and must be discarded after 7 to 14 days. Avoid storing the medicine in high-humidity areas like a bathroom.

Disposal: Unused or expired Lixin must not be disposed of in household trash or via wastewater. It must be returned to a pharmacy or disposed of according to local regulatory guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lixin found in:

A-Z Index: